T
Tito R. Mendoza
Researcher at University of Texas MD Anderson Cancer Center
Publications - 288
Citations - 20415
Tito R. Mendoza is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Cancer pain. The author has an hindex of 62, co-authored 263 publications receiving 17679 citations. Previous affiliations of Tito R. Mendoza include University of Wisconsin-Madison & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Studying Cancer-Related Fatigue: Report of the NCCN Scientific Research Committee
Joanne E. Mortimer,Andrea M. Barsevick,Charles L. Bennett,Ann M. Berger,Charles S. Cleeland,Shannon R. DeVader,Carmen P. Escalante,Jeffrey A. Gilreath,Arti Hurria,Tito R. Mendoza,Hope S. Rugo +10 more
TL;DR: A self-report questionnaire, NCCN Fatigue and Contributing Factors Inventory, is developed, which incorporates assessments of fatigue, pain, difficulty sleeping, distress, physical activity, and concurrent medications.
Journal ArticleDOI
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.
David I. Rosenthal,Tito R. Mendoza,Mark S. Chambers,V. Shannon Burkett,Adam S. Garden,Amy C. Hessell,Jan S. Lewin,K. Kian Ang,Merrill S. Kies,Ibrahima Gning,X. Wang,Charles S. Cleeland +11 more
TL;DR: The MDASI-HN, a symptom burden instrument, was more closely associated with the severity of radiation-induced mucositis than the FACT-Hn on multivariate regression analysis.
Journal ArticleDOI
Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI‐GI)
Xin Shelley Wang,Loretta A. Williams,Cathy Eng,Tito R. Mendoza,Nyma A. Shah,Karyn J. Kirkendoll,Pankil Shah,Peter C. Trask,Guadalupe R. Palos,Charles S. Cleeland +9 more
TL;DR: The authors report the development of an MDASI module for use in patients with gastrointestinal (GI) cancer (theMDASI‐GI), which was developed as a brief yet comprehensive tool to assess patient‐reported symptom severity and interference in Patients with cancer.
Journal ArticleDOI
Validation Study of the Japanese Version of the Brief Fatigue Inventory
Toru Okuyama,Xin Shelley Wang,Tatsuo Akechi,Tito R. Mendoza,Takashi Hosaka,Charles S. Cleeland,Yosuke Uchitomi +6 more
TL;DR: The results indicated that the BFI-J is a brief, valid, and feasible measure of fatigue for use with Japanese cancer patients.
Journal ArticleDOI
Validation of the Taiwanese Version of the Brief Fatigue Inventory
Chia Chin Lin,Ai Ping Chang,Mei-Ling Chen,Charles S. Cleeland,Tito R. Mendoza,Xin Shelley Wang +5 more
TL;DR: The Taiwanese version of the Brief Fatigue Inventory (BFI-T) is reliable, valid, and sensitive for measuring cancer-related fatigue severity and interference among Taiwanese cancer patients.